Compass Therapeutics, a clinical-stage biopharmaceutical company focused on oncology, announced its participation in two key investor events in June: the Jefferies Global Healthcare Conference on June 4 and the Goldman Sachs 47th Annual Global Healthcare Conference on June 9. The company will webcast presentations and offer one-on-one meetings with management. This engagement provides investors insight into Compass's progress in developing antibody-based cancer therapies targeting tumor growth and immune system pathways.
ClearSign Technologies' stock fell 20.18% in after-hours trading following the announcement of a proposed underwritten public offering of common stock. The company plans to sell new shares to raise funds for working capital, research and development,...
EC-Council has introduced the Adopt. Defend. Govern. (ADG) AI Framework and a free AI Readiness Self-Assessment Tool to help organizations securely adopt and govern AI technologies. Developed with input from major firms like Citi and Microsoft, the f...
Shrey Parikh, a 14-year-old from California, won the 2026 Scripps National Spelling Bee by correctly spelling 32 out of 35 words in a 90-second spell-off, breaking the previous record. He defeated Ishaan Gupta of New Jersey, who spelled 25 out of 29 ...
Soma Gold Corp. reported a net loss of $2.1 million in Q1 2026, down from a $3.2 million profit in the same period last year. Revenue fell 19% to $22.5 million, impacted by operational disruptions following a labor strike and mechanical issues at the...
Palantir is evolving from a traditional software-as-a-service company to a foundational AI infrastructure platform, showing strong operating momentum with Q1 adjusted operating margins of 60% and free cash flow margins of 57%. The company projects $7...
